The effect of induction pegylated interferon alfa 2b and ribavirin on early virologic response in genotype 1 chronic hepatitis C

被引：0
|
作者：
Lawitz, EJ
Harrison, SA
Cantu, NS
Davis, M
Perkel, M
Vemuru, R
Nguyen, T
Kadakia, S
Ganeshappa, KP
Diamond, K
Matossian, H
Box, TD
Ghandour, E
机构：
来源：
GASTROENTEROLOGY | 2004年 / 126卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A723 / A723
页数：1
相关论文
共 50 条
  • [1] Virologic response to treatment with Pegylated Interferon alfa-2b and Ribavirin for chronic hepatitis C in children
    Pawlowska, Malgorzata
    Pilarczyk, Malgorzata
    Halota, Waldemar
    MEDICAL SCIENCE MONITOR, 2010, 16 (12): : CR616 - CR621
  • [2] Response to Pegylated Interferon Alfa-2a and Ribavirin in Chronic Hepatitis C Genotype 4
    El Makhzangy, Hesham
    Esmat, Gamal
    Said, Mohamed
    ElRaziky, Maissa
    Shouman, Soheir
    Refai, Rasha
    Rekacewicz, Claire
    Gad, Rita Raafat
    Vignier, Nicolas
    Abdel-Hamid, Mohamed
    Zalata, Khaled
    Bedossa, Pierre
    Pol, Stanislas
    Fontanet, Arnaud
    Mohamed, Mostafa K.
    JOURNAL OF MEDICAL VIROLOGY, 2009, 81 (09) : 1576 - 1583
  • [3] Pegylated interferon alfa-2b plus ribavirin in patients with genotype 1 chronic hepatitis C with a slow virologic response: An early enrollers analysis of the success study
    Buti, Maria
    Lurie, Yoav
    Blokhina, Natalia
    Teuber, Gerlinde
    Halota, Waldermar
    Sumskiene, Jolanta
    Vozianova, Zhanna
    Wong, Florence
    Winkler, Robert
    Esteban, Rafael
    HEPATOLOGY, 2006, 44 (04) : 342A - 342A
  • [4] Response to pegylated interferon α-2b and ribavirin in children with chronic hepatitis C
    Baker, Robert D.
    Dee, Deborah
    Baker, Susan S.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2007, 41 (01) : 111 - 114
  • [5] Prospective study on early virologic response to treatment with interferon α-2b plus ribavirin in patients with chronic hepatitis C genotype 1b
    Nagaki, M
    Imose, M
    Naiki, T
    Kimura, K
    Hayashi, H
    Shimizu, M
    Ohnishi, H
    Tomita, E
    Sugihara, J
    Amano, K
    Sakai, T
    Kojima, T
    Katsumura, N
    Kondo, Y
    Fujmoto, M
    Moriwaki, H
    HEPATOLOGY RESEARCH, 2005, 33 (04) : 285 - 291
  • [6] Pegylated interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C genotype
    Hasan, F
    Asker, H
    Al-Khaldi, J
    Siddique, I
    Owaid, SF
    Al-Ajmi, M
    Al-Nakib, B
    HEPATOLOGY, 2003, 38 (04) : 629A - 629A
  • [7] Pegylated interferon α-2b, ribavirin and amantadine for chronic hepatitis C
    Younossi, ZM
    McCullough, A
    Barnes, D
    Post, A
    Ong, J
    O'Shea, R
    Martin, LM
    Bringman, D
    Farmer, D
    Levinthal, G
    Mullen, KD
    Carey, WD
    Tavill, AS
    Ferguson, R
    Gramlich, T
    DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (05) : 970 - 975
  • [8] Pegylated Interferon α-2b, Ribavirin and Amantadine for Chronic Hepatitis C
    Zobair M. Younossi
    Arthur C. McCullough
    David S. Barnes
    Anthony Post
    Janus P. Ong
    Robert O’shea
    Lisa M. Martin
    Diane Bringman
    Denise Farmer
    Gavin Levinthal
    Kevin D. Mullen
    William D. Carey
    Anthony S. Tavill
    Roy Ferguson
    Terry Gramlich
    Digestive Diseases and Sciences, 2005, 50 : 970 - 975
  • [9] Prediction of early virologic response to treatment with 40KD pegylated (PEG)-interferon (IFN) alfa2a/ribavirin in patients with chronic hepatitis C (genotype 1)
    Ferenci, P
    Jessner, W
    Hackl, F
    Gschwantier, M
    Brunner, H
    Hellmich, B
    Laferi, H
    Stauber, R
    Hubmann, R
    Datz, C
    GASTROENTEROLOGY, 2002, 122 (04) : A626 - A626
  • [10] RESPONSE FACTORS TO PEGYLATED INTERFERON-ALFA/RIBAVIRIN TREATMENT IN CHRONIC HEPATITIS C PATIENTS GENOTYPE 1B
    Jovanovic-Cupic, Snezana
    Glisic, S.
    Stanojevic, M.
    Vasiljevic, N.
    Bojic-Milinovic, T.
    Bozovic, A.
    Dimitrijevic, B.
    ARCHIVES OF BIOLOGICAL SCIENCES, 2014, 66 (01) : 193 - 201
12345